Lipocine Inc.LPCNNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+18.5%/yr
vs +12.5%/yr prior
Acceleration
+6.1pp
Accelerating
Percentile
P77
Within normal range
vs 3Y Ago
1.7x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 28.81% |
| Q3 2025 | -43.90% |
| Q2 2025 | -17.14% |
| Q1 2025 | -206.06% |
| Q4 2024 | 180.49% |
| Q3 2024 | 28.07% |
| Q2 2024 | -186.36% |
| Q1 2024 | 253.49% |
| Q4 2023 | 66.14% |
| Q3 2023 | -86.76% |
| Q2 2023 | 10.53% |
| Q1 2023 | -76.74% |
| Q4 2022 | 17.31% |
| Q3 2022 | -4.00% |
| Q2 2022 | 25.37% |
| Q1 2022 | -127.57% |
| Q4 2021 | 511.86% |
| Q3 2021 | 54.96% |
| Q2 2021 | -87.14% |
| Q1 2021 | 39.13% |
| Q4 2020 | -1.77% |
| Q3 2020 | 48.17% |
| Q2 2020 | 8.02% |
| Q1 2020 | -29.51% |
| Q4 2019 | 12.44% |
| Q3 2019 | 11.81% |
| Q2 2019 | -1.28% |
| Q1 2019 | 7.87% |
| Q4 2018 | -28.93% |
| Q3 2018 | 24.23% |
| Q2 2018 | -19.82% |
| Q1 2018 | 49.18% |
| Q4 2017 | -11.78% |
| Q3 2017 | 28.46% |
| Q2 2017 | -20.81% |
| Q1 2017 | -60.14% |
| Q4 2016 | 8.31% |
| Q3 2016 | 43.95% |
| Q2 2016 | 17.76% |
| Q1 2016 | -51.51% |